{"title":"Epirubicin-sensitive detection with a CoWO<sub>4</sub>/reduced graphene oxide modified screen-printed electrode.","authors":"Somayeh Tajik, Razieh Moghimian, Hadi Beitollahi","doi":"10.5599/admet.2733","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Because of its antimetabolic and cytotoxic qualities, epirubicin (EP), a crucial chemotherapeutic drug, has been used to treat a number of cancers, including those of the prostate, breast, ovary, stomach, lung, and colon.</p><p><strong>Experimental approach: </strong>In this study, CoWO<sub>4</sub>/reduced graphene oxide (CoWO<sub>4</sub>/rGO) nanocomposite was synthesised and characterised by field emission-scanning electron microscopy and energy-dispersive X-ray spectroscopy. To provide a novel sensing platform for EP determination, a screen-printed electrode (SPE) surface was modified using the as-fabricated CoWO<sub>4</sub>/rGO nanocomposite.</p><p><strong>Key results: </strong>Using voltammetric techniques, the electrochemical behaviour of the CoWO<sub>4</sub>/rGO nanocomposite modified SPE (CoWO<sub>4</sub>/rGO/SPE) for the EP detection was examined. CoWO<sub>4</sub>/rGO significantly reduced the overpotential of the EP redox reaction and increased the rate of electron transfer between the electrode and analyte as compared to bare SPE. EP was quantitatively analysed using differential pulse voltammetry.</p><p><strong>Conclusions: </strong>It was discovered that the linearity range was 0.01 to 190.0 μM. The sensitivity and limit of detection were 0.1529 μA μM<sup>-1</sup> and 0.007 μM, respectively. Additionally, the constructed CoWO<sub>4</sub>/rGO/SPE sensor's practical applicability was investigated in pharmaceutical samples with good recovery outcomes.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2733"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205927/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ADMET and DMPK","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5599/admet.2733","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Because of its antimetabolic and cytotoxic qualities, epirubicin (EP), a crucial chemotherapeutic drug, has been used to treat a number of cancers, including those of the prostate, breast, ovary, stomach, lung, and colon.
Experimental approach: In this study, CoWO4/reduced graphene oxide (CoWO4/rGO) nanocomposite was synthesised and characterised by field emission-scanning electron microscopy and energy-dispersive X-ray spectroscopy. To provide a novel sensing platform for EP determination, a screen-printed electrode (SPE) surface was modified using the as-fabricated CoWO4/rGO nanocomposite.
Key results: Using voltammetric techniques, the electrochemical behaviour of the CoWO4/rGO nanocomposite modified SPE (CoWO4/rGO/SPE) for the EP detection was examined. CoWO4/rGO significantly reduced the overpotential of the EP redox reaction and increased the rate of electron transfer between the electrode and analyte as compared to bare SPE. EP was quantitatively analysed using differential pulse voltammetry.
Conclusions: It was discovered that the linearity range was 0.01 to 190.0 μM. The sensitivity and limit of detection were 0.1529 μA μM-1 and 0.007 μM, respectively. Additionally, the constructed CoWO4/rGO/SPE sensor's practical applicability was investigated in pharmaceutical samples with good recovery outcomes.
期刊介绍:
ADMET and DMPK is an open access journal devoted to the rapid dissemination of new and original scientific results in all areas of absorption, distribution, metabolism, excretion, toxicology and pharmacokinetics of drugs. ADMET and DMPK publishes the following types of contributions: - Original research papers - Feature articles - Review articles - Short communications and Notes - Letters to Editors - Book reviews The scope of the Journal involves, but is not limited to, the following areas: - physico-chemical properties of drugs and methods of their determination - drug permeabilities - drug absorption - drug-drug, drug-protein, drug-membrane and drug-DNA interactions - chemical stability and degradations of drugs - instrumental methods in ADMET - drug metablic processes - routes of administration and excretion of drug - pharmacokinetic/pharmacodynamic study - quantitative structure activity/property relationship - ADME/PK modelling - Toxicology screening - Transporter identification and study